In 2024, the ultramodern unique Radixact complex (Radixact) appeared at the UMIT International Oncological Tomotherapy Center in Astana. This is a new generation of the TomoTherapy platform for IG-IMRT Radiation therapy.
Radixact is currently available in only a few cancer centers around the world.
Radixact shows best-in-class clinical results, and highly conformal and homogeneous irradiation, thanks to a unique ultrafast multi-petal collimator. Radixact system irradiates the tumor, preserves normal, healthy tissues.
The device features a fully integrated platform for intelligent treatment planning, centralized management of patient data and ultra-precise treatment.
Irradiation of tumors of any localization
It allows you to treat a wide range of oncological diseases on one platform — from simple to complex tumors.
The highest standards of treatment
Intelligent integration and automation accelerate planning, and a high—performance linear accelerator accelerates treatment.
Radiation with the least side effects
The technology uses intrafractive imaging and artificial intelligence-based treatment to accurately, accurately and at any time deliver the therapeutic fraction and adapt the position of the delivering beam to the location of the tumor. This ensures uncompromising radiation therapy. Thanks to Synchrony technology, doctors can choose the fractionation schedule that best suits the clinical needs of patients.